Medical Drugs Not Eligible for Reimbursement
Customize your policy alerts
Sign up for all Bluecross Idaho policy alerts
Know when Bluecross Idaho releases new policies or updates existing guidance.
Monitor payer policy activity
This policy identifies pharmacologic therapies and related technologies that are not eligible for reimbursement under the medical benefit, including pharmacy-benefit-only drugs, FDA-unapproved or unauthorized drugs, experimental/investigational technologies, and drugs designated not medically necessary. Coverage remains subject to the member-specific benefit plan, applicable law, and related Blue Cross of Idaho policies.
The policy tables include newly added medical-drug codes and products, including additions dated in 2026.
The policy distinguishes pharmacy-benefit-only drugs, experimental/investigational drugs, and drugs that are not medically necessary as separate categories of medical-benefit noncoverage.
The policy was revised to clarify statements about oral medications billed under major medical benefits.
Drug codes were added to Table 1 Pharmacy Benefit Medications Only and Table 3 Not Medically Necessary.
Drug codes were deleted from Table 2 Experimental/Investigational Codes.
The policy history records prior additions and removals of codes in Tables 1 and 3 and updates to Table 3 codes.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.